PURE Biosciences Inc PURE:OTCQB

Last Price$1.58NASDAQ Last Trade (15-minute delayed) as of 3:16PM ET 8/13/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+0.03(1.94%)
Bid (Size)$1.57 (254)
Ask (Size)$1.58 (13,344)
Day Low / High$1.50 - 1.58
Volume28.0 K

Read more news Recent News

Insider Trends: Insider Buy at Pure Biosciences, Slows 90-Days of Sells
6:21PM ET 6/18/2020 MT Newswires

On Jun 12, 2020, Tom Y Lee, Director and CEO, reported a purchase of 202,033 shares in Pure Biosciences (PURE) for $351,871. Subsequent to the Form 4...

Insider Trends: Pure Biosciences Insider Gets Stock Award, Trend of Buys Extended
6:07PM ET 3/12/2020 MT Newswires

On Mar 09, 2020, Dale Okuno, Director, was awarded 1,551,724 Pure Biosciences (PURE) shares having an approximate value of $837,931 based on the daily...

Insider Trends: Insider 90-Day Selling Trend Extended at Pure Biosciences
6:56PM ET 2/10/2020 MT Newswires

Dale Okuno, Director, sold 788,880 shares in Pure Biosciences (PURE) for $228,375 on Dec 19, 2019. Subsequent to the Form 4 filing with the SEC, Okuno...

Insider Trends: Pure Biosciences Insider Buy Scaling Back 90-Days of Sells
6:53PM ET 2/10/2020 MT Newswires

Tom Y Lee, Director, executed a purchase for 754,884 shares of Pure Biosciences (PURE) on Dec 19, 2019, for $218,161. Lee has control over 29,971,225...

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionPURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA. View company web site for more details
Address9669 Hermosa Avenue
Rancho Cucamonga, California 91730
Number of Employees11
Recent SEC Filing06/26/20204
Chairman, President & Chief Executive OfficerTom Y. Lee
Chief Operating OfficerTom Myers
CFO, Principal Accounting Officer & VP-FinanceMark S. Elliott
VP-Technology Development & Regulatory AffairsDolana Blount

Company Highlights

Price Open$1.53
Previous Close$1.55
52 Week Range$0.20 - 2.05
Market Capitalization$137.6 M
Shares Outstanding87.1 M
SectorProcess Industries
IndustryChemicals: Major Diversified
Next Earnings Announcement11/03/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.03
Beta vs. S&P 500N/A
Revenue$1.8 M
Net Profit Margin-59.68%
Return on Equity-129.24%

Analyst Ratings as of 08/05/2011

Consensus RecommendationConsensus Icon
Powered by Factset